Generation Bio

Generation Bio CROIC

Delisted

The Cash Return on Invested Capital (CROIC) of Generation Bio (GBIO) as of Nov 10, 2026 is -105.52 %. In the previous year, Cash Return on Invested Capital (CROIC) was -29.61 % — a change of 256.40% (lower).

CROIC

-105.52 %

YoY

256.40%

Last updated:

Cash Return on Invested Capital (CROIC) of Generation Bio is 2024 -105.52 % . Cash Return on Invested Capital (CROIC) of Generation Bio was 2023 -29.61 % . It decreases by 256.40% lower compared to the previous year.

The Generation Bio CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
74.87 USD
Jan 1, 2019
61.19 USD
Jan 1, 2020
-28.23 USD
Jan 1, 2021
-25.61 USD
Jan 1, 2022
-39.38 USD
Jan 1, 2023
-29.61 USD
Jan 1, 2024
-105.52 USD
The Generation Bio CROIC history
YEARCROICYoY
-105.52 %+256.40%
-29.61 %-24.82%
-39.38 %+53.75%
-25.61 %-9.27%
-28.23 %-146.13%
61.19 %-18.27%
74.87 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Generation Bio Stock analysis

What does Generation Bio do? Generation Bio Co. is a genetic medicines company headquartered in Cambridge, Massachusetts, that focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. The firm is developing a class of gene therapy utilizing its non-viral gene therapy platform to deliver genetic payloads to a range of tissues. The company’s non-viral gene therapy platform includes its DNA construct called closed-ended DNA (ceDNA), its cell-targeted lipid nanoparticle delivery system (ctLNP) and its established, scalable capsid-free manufacturing process. The firm is engineering its gene therapies to be redosable, which enable patient titration to reach the desired therapeutic expression and to maintain efficiency in a patient’s life. The firm is a preclinical stage company and have not identified a product candidate. Generation Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Generation Bio stock

Cash Return on Invested Capital (CROIC) of Generation Bio is -105.52 % in 2024.

Cash Return on Invested Capital (CROIC) of Generation Bio changed from -29.61 % to -105.52 %, representing a 256.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Generation Bio since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Generation Bio with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Generation Bio

All Key Metrics — Generation Bio